Please use this identifier to cite or link to this item: https://repositorio.unifesp.br/handle/11600/30585
Title: Optimized cutoffs improve performance of the aspartate aminotransferase to platelet ratio index for predicting significant liver fibrosis in human immunodeficiency virus/hepatitis C virus co-infection
Authors: Carvalho-Filho, Roberto J. [UNIFESP]
Schiavon, Leonardo L. [UNIFESP]
Narciso-Schiavon, Janaina L. [UNIFESP]
Sampaio, Juliana P. [UNIFESP]
Lanzoni, Valeria P. [UNIFESP]
Ferraz, Maria Lucia G. [UNIFESP]
Silva, Antonio Eduardo B. [UNIFESP]
Universidade Federal de São Paulo (UNIFESP)
Keywords: co-infection
fibrosis markers
hepatitis C
HIV
liver fibrosis
Issue Date: 1-Apr-2008
Publisher: Blackwell Publishing
Citation: Liver International. Oxford: Blackwell Publishing, v. 28, n. 4, p. 486-493, 2008.
Abstract: Aim: To assess the diagnostic value of modified cutoffs for aspartate aminotransferase to platelet ratio index (APRI) to predict significant liver fibrosis in human immunodeficiency virus (HIV)/hepatitis C virus (HCV) patients. Methods: This retrospective cross-sectional study included consecutive patients with HIV/HCV co-infection who underwent percutaneous liver biopsy. the accuracy of APRI for the diagnosis of significant fibrosis (F2/F3/F4 METAVIR) was evaluated by estimating the positive and negative predictive values (PPV and NPV respectively) and by measuring the area under the receiver operating characteristics curve (AUROC). Results: One hundred and eleven patients were included (73% men, mean age 40.2 +/- 7.8 years). Significant fibrosis was observed in 45 patients (41%). To discriminate these subjects, the AUROC of APRI was 0.774 +/- 0.045. An APRI >= 1.8 showed a PPV of 75% for the presence of significant fibrosis, and an index < 0.6 excluded significant fibrosis with an NPV of 87%. If biopsy indication was based only on APRI and restricted to scores in the intermediate range (>= 0.6 and < 1.8), 46% of liver biopsies could have been avoided as compared with 40% using the classical cutoffs. Conclusion: APRI with adjusted cutoffs can predict significant liver fibrosis in patients with HIV/HCV co-infection and might obviate the need to perform a biopsy in a considerable percentage of those subjects.
URI: http://repositorio.unifesp.br/handle/11600/30585
ISSN: 1478-3223
Other Identifiers: http://dx.doi.org/10.1111/j.1478-3231.2008.01675.x
Appears in Collections:Em verificação - Geral

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.